Francis Knuettel II 4
4 · 180 Life Sciences Corp. · Filed Sep 8, 2023
Insider Transaction Report
Form 4
Francis Knuettel II
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2023-09-04+15,000→ 15,000 totalExercise: $0.67Exp: 2033-09-04→ Common Stock (15,000 underlying)
Holdings
- 0
Common Stock
Footnotes (2)
- [F1]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F2]The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.